| 000 | 01211 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516064308.0 | ||
| 264 | 0 | _c20120116 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1474-4465 | ||
| 024 | 7 |
_a10.1016/S1474-4422(11)70245-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTitulaer, Maarten J | |
| 245 | 0 | 0 |
_aLambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. _h[electronic resource] |
| 260 |
_bThe Lancet. Neurology _cDec 2011 |
||
| 300 |
_a1098-107 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_a4-Aminopyridine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAmifampridine |
| 650 | 0 | 4 |
_aAutoantibodies _ximmunology |
| 650 | 0 | 4 |
_aCalcium Channels _ximmunology |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLambert-Eaton Myasthenic Syndrome _xcomplications |
| 650 | 0 | 4 |
_aLung Neoplasms _xcomplications |
| 700 | 1 | _aLang, Bethan | |
| 700 | 1 | _aVerschuuren, Jan Jgm | |
| 773 | 0 |
_tThe Lancet. Neurology _gvol. 10 _gno. 12 _gp. 1098-107 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1474-4422(11)70245-9 _zAvailable from publisher's website |
| 999 |
_c21321677 _d21321677 |
||